Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
Invagen Pharmaceuticals
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
10.0%
-3.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Amneal Pharmaceuticals
Competitor Displacement Rate
12.0%
Competitors are displacing Invagen Pharmaceuticals in 12.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: Amneal Pharmaceuticals frequently dominates generic drug search results, indicating a strong market presence and broader portfolio visibility.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[amneal.com][goodrx.com]⚠️ Identified Vulnerability:Generic Portfolio
Primary Threat Identified:Amneal Pharmaceuticals
Target Persona:Pharmacists and Healthcare Providers sourcing generic medications
🚨 Threat Velocity:5/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)